<!DOCTYPE html>
<head>
    <meta charset="utf-8">
    <title>Rem Abstarct</title>
    <link href="Cure Decor.css" rel="stylesheet">
</head>
<header>
    <div class="navi">
      <p><a href="Scan to Cure.html">Scan to Cure</a></p>
      <ul>
        <li><a href="#">Covid Overview</a>
          <ul>
            <li><a href="Structure.html">Structure of the Covid Molecule</a></li>
          </ul>
        </li>
          
        <li><a href="#">General Info of COVID Pro-Drugs</a>
          <ul>
            <li><a href="Remdesivier Abstract.html">Remdesivir</a></li>
            <li><a href="Fluvoxamine Abstract.html">Fluvoxamine</a></li>
            <li><a href="Molnupiravir Abstract.html">Molnupiravir</a></li>
          </ul>
        </li>
        <li><a href="#">Mechanism of Action</a>
          <ul>
            <li><a href='Remdesivier.html'>Remdesivir</a></li>
            <li><a href='Fluvoxamine.html'>Fluvoxamine</a></li>
            <li><a href='Molnupiravir.html'>Molnupiravir</a></li>
          </ul>
        </li>
        <li><a href='Similarities & Differences.html'>Similarities & Differences</a></li>
            <li><a href='Literature Sources.html'>Literature Source</a></li>
      </ul>
    </div>


  </header>
<body>
  <div class = "for">
    <h2>Remdesivir</h2>
        <h4>Abstract</h4>
        <br>
        <p>
            Remdesivir has broad-spectrum antiviral action against many single-stranded RNA  viruses including pathogenic SAR-CoV and the Middle East respiratory syndrome  coronavirus (MERS-CoV). In this study, we proposed that remdesivir strongly binds to  membrane protein (Mprotein), RNA-dependent RNA polymerase (RDRP), and main  protease (Mprotease) of SARS- CO V-2. The structure dynamics study suggested binding of  remdesivir leads to unfolding of RDRP. Binding of remdesivir to Mprotease, Mprotein, and  RDRP reduces the average motions in protein due to its strong binding. Remdesivir is a  metabolically active from (GS-441524) that works by inhibiting viral RNA-dependent RNA  polymerase (RDRP) while evading proofreading by viral exoribonuclease, which leads to  premature termination of viral RNA transcription and hence inhibits the spread of the virus  as well as the production of viral RNA (Wang M. et al., 2020). It showed possible binding  and inhibitory mechanisms of remdesivir on the C-terminal domain of SARS-CoV-2  nucleocapsid protein (CTD), envelope protein (Eprotein), main protease (Mprotease),  membranes protein (Mprotease), membrane phosphoprotein (NTD), RDRP, and spike  protein (Sprotein) using several computational approaches. It shows strong inhibitory effects  on Mprotein, RDRP, and spike protein (Sprotein, Figure 1G) using several computational  approaches. It shows strong inhibitory effects on Mprotein, RDRP (Figure 1D), and  Mprotease of SARS-CoV-2.  
        </p>
        <p><img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTWDG6YgUvnBmmgXE892fb8ACFusqSIsymXog:https://d2cbg94ubxgsnp.cloudfront.net/Pictures/web/e/n/p/remdesivir_564415.svgz&usqp=CAU" height="600" width="700"></p>
        <p><img src="https://www.grxstatic.com/d4fuqqd5l3dbz/products/Package_25772.JPG" height="600" width="700"></p>
  </div>
</body>
</html>